MDL 4101
Alternative Names: MDL-4101Latest Information Update: 16 Jan 2025
Price :
$50 *
At a glance
- Originator Model Medicines
- Class Antineoplastics; Small molecules
- Mechanism of Action BRD4 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Thyroid cancer